CAPR vs. KPTI
CAPR (Capricor Therapeutics, Inc.) and KPTI (Karyopharm Therapeutics Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, CAPR returned -2.03%/yr vs -23.75%/yr for KPTI. At a 0.19 correlation, their price movements are largely independent.
Performance
CAPR vs. KPTI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CAPR achieves a -9.36% return, which is significantly lower than KPTI's 15.49% return. Over the past 10 years, CAPR has outperformed KPTI with an annualized return of -2.03%, while KPTI has yielded a comparatively lower -23.75% annualized return.
CAPR
- 1D
- -2.06%
- 1M
- -13.89%
- YTD
- -9.36%
- 6M
- -8.40%
- 1Y
- 83.84%
- 3Y*
- 77.22%
- 5Y*
- 42.20%
- 10Y*
- -2.03%
KPTI
- 1D
- -6.39%
- 1M
- -1.62%
- YTD
- 15.49%
- 6M
- 44.31%
- 1Y
- 89.31%
- 3Y*
- -36.47%
- 5Y*
- -43.70%
- 10Y*
- -23.75%
CAPR vs. KPTI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CAPR Capricor Therapeutics, Inc. | -9.36% | 109.13% | 182.21% | 26.68% | 31.74% | -14.58% | 167.97% | -68.78% | -74.05% | -40.60% |
KPTI Karyopharm Therapeutics Inc. | 15.49% | -27.45% | -21.82% | -74.56% | -47.12% | -58.46% | -19.25% | 104.59% | -2.40% | 2.13% |
Correlation
The correlation between CAPR and KPTI is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.24 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Nov 7, 2013 | 0.19 |
The correlation between CAPR and KPTI shifts across timeframes, from 0.08 (1 year) to 0.24 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
CAPR:
$1.50B
KPTI:
$210.08M
CAPR:
-$2.32
KPTI:
-$13.00
CAPR:
$0.00
KPTI:
$151.12M
CAPR:
-$42.41M
KPTI:
$145.13M
CAPR:
-$117.24M
KPTI:
-$93.05M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CAPR vs. KPTI — Risk / Return Rank
CAPR
KPTI
CAPR vs. KPTI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Capricor Therapeutics, Inc. (CAPR) and Karyopharm Therapeutics Inc. (KPTI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CAPR | KPTI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.73 | ||
| Sortino ratioReturn per unit of downside risk | +2.54 | ||
| Omega ratioGain probability vs. loss probability | 1.59 | 1.22 | +0.37 |
| Calmar ratioReturn relative to maximum drawdown | 1.26 | 1.86 | -0.60 |
| Martin ratioReturn relative to average drawdown | 2.38 | 4.59 | -2.21 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CAPR | KPTI | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.22 | 0.95 | -0.73 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.22 | -0.46 | +0.69 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.01 | -0.28 | +0.26 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.08 | -0.27 | +0.18 |
Drawdowns
CAPR vs. KPTI - Drawdown Comparison
The maximum CAPR drawdown since its inception was -99.97%, roughly equal to the maximum KPTI drawdown of -99.50%. Use the drawdown chart below to compare losses from any high point for CAPR and KPTI.
Loading charts...
Drawdown Indicators
| CAPR | KPTI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.97% | -99.50% | -0.47% |
Max Drawdown (1Y)Largest decline over 1 year | -67.00% | -48.36% | -18.64% |
Max Drawdown (3Y)Largest decline over 3 years | -79.08% | -89.32% | +10.24% |
Max Drawdown (5Y)Largest decline over 5 years | -79.08% | -98.36% | +19.28% |
Max Drawdown (10Y)Largest decline over 10 years | -98.02% | -99.15% | +1.13% |
Current DrawdownCurrent decline from peak | -99.20% | -98.80% | -0.40% |
Average DrawdownAverage peak-to-trough decline | -90.24% | -75.28% | -14.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 35.96% | 19.53% | +16.43% |
Volatility
CAPR vs. KPTI - Volatility Comparison
The current volatility for Capricor Therapeutics, Inc. (CAPR) is 18.21%, while Karyopharm Therapeutics Inc. (KPTI) has a volatility of 24.86%. This indicates that CAPR experiences smaller price fluctuations and is considered to be less risky than KPTI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CAPR | KPTI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.21% | 24.86% | -6.65% |
Volatility (6M)Calculated over the trailing 6-month period | 50.01% | 62.32% | -12.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 385.34% | 94.32% | +291.02% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 190.06% | 94.91% | +95.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 179.86% | 86.51% | +93.35% |
Dividends
CAPR vs. KPTI - Dividend Comparison
Neither CAPR nor KPTI has paid dividends to shareholders.
Financials
CAPR vs. KPTI - Financials Comparison
This section allows you to compare key financial metrics between Capricor Therapeutics, Inc. and Karyopharm Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CAPR and KPTI have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KPTI has higher volatility (24.86%) compared to CAPR (18.21%). In terms of maximum drawdown, CAPR dropped -99.97% vs KPTI's -99.50%.
KPTI currently has the higher Sharpe Ratio (0.95 vs 0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CAPR and KPTI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer